JL

Judy LeBrew

Person

Heard in 4 episodes across 2 shows since Aug 2026

Judy LeBrew is a guest who discussed Piper Sandler and its stock ticker, PIPR.

Episodes

4
across 2 shows

First heard

Aug 2026

Guest appearances

3

Episodes per month

Public PodLume episodes featuring it, over the last year.

Show the data
MonthEpisodes
Nov 20250
Dec 20250
Jan 20260
Feb 20260
Mar 20260
Apr 20260
May 20260
Jun 20260
Jul 20260
Aug 20261
Sep 20263
Oct 20260

What Judy LeBrew has said on podcasts

1 statement

  1. on AstraZeneca investment and cancer-drug collaboration with Summit TherapeuticsPositiveSep 29, 2026· Stock Movers

    AstraZeneca agreed to invest $2 billion in Summit Therapeutics and collaborate on a cancer drug.

    “AstraZeneca agreed to invest $2 billion in Summit Therapeutics to collaborate on a promising new cancer medication”

    Listen at 2:06

    Open the episode · Piper Sandler Drops, Summit Therapeutics Jumps, Fair Isaac Sinks as New Policy Seen Spurring Competition

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

Episodes

4 episodes featuring Judy LeBrew, newest first